Hostname: page-component-55f67697df-q9hcs Total loading time: 0 Render date: 2025-05-09T10:11:17.314Z Has data issue: false hasContentIssue false
  • English
  • Français

Do Benzodiazepines Still Deserve a Major Role in The Treatment of Psychiatric Disorders? A Critical Reappraisal

Published online by Cambridge University Press:  20 April 2013

B. Dell’osso  and
M. Lader
B. Dell’osso*
Affiliation:
Department of Neurological Sciences, University of Milan, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122Milano, Italy
M. Lader
Affiliation:
Institute of Psychiatry, King's College London, London, UK
*
⁎Corresponding author. Tel.: +02-55035994; fax: +02-50320310. E-mail address: [email protected] (B. Dell'osso).
Get access

Abstract

Discovered in the late 1950s by Leo Sternbach, the first benzodiazepine (BZD) chlordiazepoxide was followed by several congeners, which rapidly constituted one of the largest and most widely prescribed classes of psychotropic compounds. After 50 years, BZDs are still routinely utilized not only in psychiatry but, more generally, in the whole of medicine. Despite their high therapeutic index which makes BZDs safer than other compounds like barbiturates, as well as their rapidity of onset, psychiatrists and family physicians are well aware about the controversy that surrounds the wide use – often not adequately based on scientific evidence – of BZDs in many psychiatric disorders. In this overview of international treatment guidelines, systematic reviews and randomized clinical trials, the aim was to provide a critical appraisal of the current use and role of BZDs in psychiatric disorders and their disadvantages, with specific emphasis on anxiety and affective disorders, sleep disorders, alcohol withdrawal, violent and aggressive behaviours in psychoses, and neuroleptic-induced disorders. In addition, specific emphasis has been given to the extent of usage of BZDs and its appropriateness through the assessment of available international surveys. Finally, the entire spectrum of BZD-related adverse effects including psychomotor effects, use in the elderly, paradoxical reactions, tolerance and rebound, teratologic risk, dependence, withdrawal and abuse issues was examined in detail.

Keywords

Benzodiazepines (BZDs)Anxiety disordersSleep disordersAlcohol withdrawalViolent and aggressive behaviours in psychosesNeuroleptic-induced disordersExtent of usageAdverse effects
Type
Review
Information
European Psychiatry , Volume 28 , Issue 1 , January 2013 , pp. 7 - 20
Copyright
Copyright © European Psychiatric Association 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Allain, H.Bentué-Ferrer, D.Polard, E.Akwa, Y.Patat, A.Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging 2005;22:749–765.CrossRefGoogle ScholarPubMed
Amato, L.Minozzi, S.Vecchi, S.Davoli, M.Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2010;3:CD005063.Google Scholar
American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics 1998;101:1079–1088.Google Scholar
American College of Obstetricians and Gynecologists. Committee on Practice Bulletins-Ostetrics. ACOG Practice Bulletin no. 92 November 2007: use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008;111:1001–1020.Google Scholar
American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, third edition. Washington DC: Arlington (VA); 2010, 152 p.Google Scholar
Ansseau, M.Olié, J.P.von Frenckell, R.Jourdain, G.Stehle, B.Guillet, P.Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder. Psychopharmacology (Berl) 1991;104:439–443.CrossRefGoogle ScholarPubMed
Ashok, R.Sheehan, D.V.Benzodiazepines. Schatzberg, A.F.Nemeroff, C.B.Essentials of Clinical Psychopharmacology. VA (USA): American Psychiatric Publishing; 2006. 539–569.Google Scholar
Ashton, C.H.Protracted withdrawal syndromes from benzodiazepines. J Subst Abuse Treat 1991;8:19–28.CrossRefGoogle ScholarPubMed
Ashton, C.H.Benzodiazepines: How they work and how to withdraw. (Revised Edition 2011). Newcastle: University of Newcastle; 2002.Google Scholar
Attard, A.Ranjith, G.Taylor, D.Delirium and its treatment. CNS Drugs 2008;22:631–644.CrossRefGoogle ScholarPubMed
Baenninger, A.Costa e Silva, J.A.Hindmarch, A.Moeller, H.J.Rickels, K.Good chemistry: the life and legacy of valium inventor Leo Sternbach. New York; McGraw-Hill; 2004.Google Scholar
Bain, K.T.Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother 2006;4:168–192.CrossRefGoogle ScholarPubMed
Baldwin, D.Woods, R.Lawson, R.Taylor, D.Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ 2011;11:1199.CrossRefGoogle Scholar
Ban, T.A.In memory of three pioneers. Int J Neuropsychopharmacol 2006;9:475–477.CrossRefGoogle ScholarPubMed
Bandelow, B.Zohar, J.Hollander, E.Kasper, S.Möller, H.J.on behalf of the WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – first revision. World J Biol Psychiatry 2008;9:248–312.CrossRefGoogle Scholar
Barbee, J.G.Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives. J Clin Psychiatry 1993;54(Suppl. 10):86–97.Google ScholarPubMed
Barbone, F.McMahon, A.D.Davey, P.G.Association of road-traffic accidents with benzodiazepine use. Lancet 1998;352:1331–1336.CrossRefGoogle ScholarPubMed
Barbui, C.Cipriani, A.Patel, V.Ayuso-Mateos, J.L.Van Ommeren, M.Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry 2011;198:11–16.CrossRefGoogle ScholarPubMed
Barker, M.J.Greenwood, K.M.Jackson, M.Crowe, S.F.Cognitive effects of long-term benzodiazepine use. CNS Drugs 2004;18:37–47.CrossRefGoogle ScholarPubMed
Batty, G.M.Osborne, C.A.Swift, C.G.Jackson, S.H.Development of an indicator to identify inappropriate use of benzodiazepines in elderly medical in-patients. Int J Geriatr Psychiatry 2000;15:892–896.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Bayer, A.J.Bayer, E.M.Pathy, M.S.J.Stoker, M.J.A Double-blind controlled study of chlormethiazole and triazolam as hypnotics in the elderly. Acta Psychiatr Scand 1986;73(Suppl. 329):104–111.CrossRefGoogle Scholar
Bhoopathi, P.S.Soares-Weiser, K.Benzodiazepines for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev 2006;3:CD000205.Google Scholar
Bond, A.J.Seijas, D.Dawling, S.Lader, M.H.Systematic absorption and abuse liability of snorted flunitrazepam. Addiction 1994;89:821–830.CrossRefGoogle Scholar
Bond, A.J.Silveira, J.C.Lader, M.H.Effects of single doses of alprazolam alone and alcohol alone and in combination on psychological performance. Hum Psychopharmacol 1991;6:219–228.CrossRefGoogle Scholar
Bond, A.J.Drug-induced behavioural disinhibition: incidence, mechanisms and therapeutic implications. CNS Drugs 1998;9:41–57.CrossRefGoogle Scholar
Boyer, W.F.Feighner, J.P.A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder. Int Clin Psychopharmacol 1993;8:173–176.CrossRefGoogle ScholarPubMed
Braun, P.Greenberg, D.Dasberg, H.Lerer, B.Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry 1990;51:236–238.Google ScholarPubMed
Buffett-Jerrott, S.E.Stewart, S.H.Cognitive and sedative effects of benzodiazepine use. Current Pharmacological Des 2002;8:45–58.CrossRefGoogle ScholarPubMed
Byrne, J.Insomnia in older people: current approaches to treatment. Prescriber 2006;19:54–56.Google Scholar
Castleden, C.M.George, C.F.Marcer, D.Hallett, C.Increased sensitivity to nitrazepam in old age. BMJ 1977;1:10–12.CrossRefGoogle ScholarPubMed
Charlson, F.Degenhardt, L.McLaren, J.Hall, W.Lynskey, M.A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf 2009;18:93–103.CrossRefGoogle ScholarPubMed
Chouinard, G.Annable, L.Fontaine, R.Solyom, L.Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study. Psychopharmacology (Berl) 1982;77:229–233.CrossRefGoogle ScholarPubMed
Ciuna, A.Andretta, M.Corbari, L.Levi, D.Mirandola, M.Sorio, A.Are we going to increase the use of antidepressants up to that of benzodiazepines?. Eur J Clin Pharmacol 2004;60:629–634.CrossRefGoogle ScholarPubMed
Cloos, J.M.Ferreira, V.Current use of benzodiazepines in anxiety disorders. Curr Opin Psychiatry 2009;22:90–95.CrossRefGoogle ScholarPubMed
Colman, I.Wadsworth, M.E.Croudace, T.J.Jones, P.B.Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort. Br J Psychiatry 2006;189:156–160.CrossRefGoogle Scholar
Cook, P.J.Huggett, A.Graham-Pole, R.Savage, I.T.James, I.A.Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam. BMJ 1983;286:100–102.CrossRefGoogle ScholarPubMed
Cortese, L.Pourcher-Bouchard, E.Williams, R.Assessment and management of antipsychotic-induced adverse events. Can J Psychiatry 1998;43(Suppl. 1):15–20.CrossRefGoogle ScholarPubMed
Crockett, B.A.Churchill, E.Davidson, J.R.A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder. Ann Clin Psychiatry 2004;16:127–132.CrossRefGoogle ScholarPubMed
Cumming, R.G.Le Couteur, D.G.Benzodiazepines and risk of hip fractures in older people. CNS Drugs 2003;17:825–837.CrossRefGoogle ScholarPubMed
Cunningham, C.M.Hanley, G.E.Morgan, S.Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guidelines cautions against long-term use. Health Policy 2010;97:122–129.CrossRefGoogle Scholar
Curran, H.V., Benzodiazepines memory and mood: a review. Psychopharmacology (Berl) 1991;105:1–8.Google ScholarPubMed
Curran, H.V.Tranquillising memories: a review of the effects of benzodiazepines on human memory. Biol Psychol 1986;23:179–213.CrossRefGoogle ScholarPubMed
Darke, S.Benzodiazepine use among injecting drug users: problems and implications. Addiction 1994;89:379–382.CrossRefGoogle ScholarPubMed
Dassanayake, T.Michie, P.Carter, G.Jones, A.Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug Safety 2011;34:125–156.CrossRefGoogle ScholarPubMed
Davidson, J.R.Potts, N.Richichi, E.Krishnan, R.Ford, S.M.Smith, R.Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993;13:423–428.CrossRefGoogle ScholarPubMed
Davidson, J.R.Zhang, W.Connor, K.M.Ji, J.Jobson, K.Lecrubier, Y.A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD). J Psychopharmacol 2010;24:3–26.CrossRefGoogle Scholar
Davidson, J.R.Connor, K.M.Treatment of anxiety disorders. In: Schatzberg, A.Nemeroff, C.B.Essentials of Clinical Psychopharmacology VA (USA): American Psychiatric Publishing; 2006.1425–1466.Google Scholar
De Gier, N.Gorgels, W.Lucassen, P.Voshaar, O.R.Mulder, J.Zitman, F.Discontinuation of long-term benzodiazepine use: 10-year follow-up. Fam Pract 2011;28(3):253–259.CrossRefGoogle ScholarPubMed
De Wit, H.Griffiths, R.R.Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug Alcohol Depend 1991;28:83–111.CrossRefGoogle ScholarPubMed
Denis, C.Fatséas, M.Lavie, E.Auriacombe, M.Pharmacological interventions for mono-dependence benzodiazepine management in outpatient settings. Cochrane Database Syst Rev 2006;3:CD005194.Google Scholar
Dikeos, D.G.Soldatos, C.R.The pharmacotherapy of insomnia: Efficacy and rebound with hypnotic drugs. Prim Care Companion J Clin Psychiatry 2001;4(Suppl. 1):27–32.Google Scholar
Dolovich, L.R.Addis, A.Vaillancourt, J.M.Power, J.D.Koren, G.Einarson, T.R.Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ 1998;317:839–843.CrossRefGoogle ScholarPubMed
Donoghue, J.Lader, M.Usage of benzodiazepines; a review. Int J Psychiatry in Clin Pract 2010;14:78–87.CrossRefGoogle ScholarPubMed
Drummer, O.H.Benzodiazepines-effects on human performance and behaviour. Forensic Science Review 2002;14:1–14.Google Scholar
Dunner, D.L.Ishiki, D.Avery, D.H.Wilson, L.G.Hyde, T.S.Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. J Clin Psychiatry 1986;47:458–460.Google ScholarPubMed
Einarson, A.Selby, P.Koren, G.Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J Psychiatry Neurosci 2001;26:44–48.Google ScholarPubMed
Elie, R.Lamontagne, Y.Alprazolam and diazepam in the treatment of generalized anxiety. J Clin Psychopharmacol 1984;4:125–129.CrossRefGoogle ScholarPubMed
Enkelmann, R.Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology (Berl) 1991;105:428–432.CrossRefGoogle ScholarPubMed
Erman, M.K.Benzodiazepine receptor agonists. The black book of insomnia 1st ed. New York: MBL Communication, Inc; 2009, p. 24–7.Google Scholar
Fairweather, D.B.Kerr, J.S.Hindmarch, I.The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers. Eur J Clin Pharmacol 1992;43:597–601.CrossRefGoogle ScholarPubMed
Feighner, J.P.Merideth, C.H.Hendrickson, G.A.A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. J Clin Psychiatry 1982;43:103–108.Google ScholarPubMed
Feltner, D.E.Crockatt, J.G.Dubovsky, S.J.Cohn, C.K.Shrivastava, R.K.Targum, S.D.A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 2003;23:240–249.CrossRefGoogle ScholarPubMed
Fontaine, R.Annable, L.Chouinard, G.Ogilvie, R.I.Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations. J Clin Psychopharmacol 1983;3:80–87.CrossRefGoogle ScholarPubMed
Fraser, A.D.Use and abuse of the benzodiazepines. Ther Drug Monit 1998;20:481–489.CrossRefGoogle ScholarPubMed
Furukawa, T.A.Streiner, D.L.Young, L.T.Antidepressant plus benzodiazepine for major depression. Cochrane Database Syst Rev 2001;2:CD001026.Google Scholar
Gelernter, C.S.Uhde, T.W.Cimbolic, P.Arnkoff, D.B.Vittone, B.J.Tancer, M.E.Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry 1991;48:938–945.CrossRefGoogle ScholarPubMed
Gelpin, E.Bonne, O.Peri, T.Brandes, D.Shalev, A.Y.Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 1996;57:390–394.Google ScholarPubMed
Gerra, G.Zaimovic, A.Giusti, F.Moi, G.Brewer, C.Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomised, placebo-controlled study. Addict Biol 2002;7:385–395.CrossRefGoogle Scholar
Gillies, D.Beck, A.McCloud, A.Rathbone, J.Gillies, D.Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. Cochrane Database Syst Rev 2005;4:CD003079.Google Scholar
Golombok, S.Moodley, P.Lader, M.Cognitive impairment in long-term benzodiazepine users. Psychol Med 1988;18:365–374.CrossRefGoogle ScholarPubMed
Goodwin, R.D.Hasin, D.S.Sedative use and misuse in the United States. Addiction 2001;97:555–562.CrossRefGoogle Scholar
Gorenstein, G.Bernik, M.A.Pompéia, S.Impairment of performance associated with long-term use of benzodiazepines. J Psychopharmacol 1995;9:313–318.CrossRefGoogle ScholarPubMed
Hallstrom, C.Lader, M.H.Benzodiazepine withdrawal phenomena. Int Pharmacopsychiatry 1981;16:235–244.CrossRefGoogle ScholarPubMed
Hammersley, D.Beeley, L.The effects of medication on counselling. Palmer, S.Dainow, S.Milner, P.Counselling: the BACP Counselling Reader London: Sage; 1996.211–214.Google Scholar
Heather N, Paton J, Ashton H. Predictors of response to brief intervention in general practice against long-term benzodiazepine use. Posted online on May 6, 2011. (doi:10.3109/16066359.2011.569102). Accessed 7 June 2011.CrossRefGoogle Scholar
Hewlett, W.A.Vinogradov, S.Agras, W.S.Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol 1992;12:420–430.CrossRefGoogle ScholarPubMed
Higgitt, A.Fonagy, P.Lader, M.The natural history of tolerance to the benzodiazepines. Psychol Med Monogr Suppl 1988;13:1–55.CrossRefGoogle ScholarPubMed
Higgitt, A.Fonagy, P.Toone, B.Shine, P.The prolonged benzodiazepine withdrawal syndrome: anxiety or hysteria?. Acta Psychiatr Scand 1990;89:165–168.CrossRefGoogle Scholar
Higgitt, A.C.Lader, M.H.Fonagy, P.Clinical management of benzodiazepine dependence. Br Med J 1985;291:688–690.CrossRefGoogle ScholarPubMed
Hoehn-Saric, R.McLeod, D.R.Zimmerli, W.D.Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. J Clin Psychiatry 1988;49:293–301.Google ScholarPubMed
Hollander, E.Kaplan, A.Stahl, S.M.A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder. World J Biol Psychiatry 2003;4:30.CrossRefGoogle ScholarPubMed
Hollander, E.Kim, S.Khanna, S.Pallanti, S.Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders: diagnostic and dimensional issues. CNS Spectr 2007;12(Suppl. 3):5–13.CrossRefGoogle Scholar
Hollister, L.E.Motzenbecker, F.P.Degan, R.O.Withdrawal reactions to chlordiazepoxide (“Librium”). Psychopharmacologia 1961;2:63–68.CrossRefGoogle Scholar
Hughes, J.R.Alcohol withdrawal seizures. Epilepsy Behav 2009;15:92–97.CrossRefGoogle ScholarPubMed
Hulse, G.K.Lautenschlager, N.T.Tait, R.J.Almeida, O.P.Dementia associated with alcohol and other drug use. Int Psychogeriatr 2005;17(Suppl. 1:109–127.CrossRefGoogle ScholarPubMed
Iqbal, M.M.Sobhan, T.Ryals, T.Effects of commonly used benzodiazepines on the fetus, the neonate and the nursing infant. Psychiatr Serv 2002;53:39–49.CrossRefGoogle ScholarPubMed
Iqbal, N.Lambert, T.Masand, P.Akathisia: problem of history or concern of today. CNS Spectr 12 2007;(Suppl. 14):1–13.CrossRefGoogle ScholarPubMed
Jacobson, A.F.Dominguez, R.A.Goldstein, B.J.Steinbook, R.M.Comparison of buspirone and diazepam in generalized anxiety disorder. Pharmacotherapy 1985;5:290–296.CrossRefGoogle ScholarPubMed
Kennedy, S.H.Lam, R.W.Parikh, S.V.Patten, S.B.Ravindran, A.V.Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. J Affect Disord 2009;117:S5–S14.Google ScholarPubMed
Knijnik, D.Z.Blanco, C.Salum, G.A.Moraes, C.U.Mombach, C.Almeida, E.A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder. Eur Psychiatry 2008;23:567–574.CrossRefGoogle ScholarPubMed
Koran, L.M.Aboujaoude, E.Bullock, K.D.Franz, B.Gamel, N.Elliott, M.Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 2005;66:353–359.CrossRefGoogle ScholarPubMed
Koran, L.M.Hanna, G.L.Hollander, E.Nestadt, G.Simpson, H.B.American Psychiatric Association. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 164(Suppl. 7):2007 5–53.Google ScholarPubMed
Krystal, A.D.Walsh, J.K.Laska, E.Caron, J.Amato, D.A.Wessel, T.C.Roth, T.Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep. 2003 26(7):793–799.CrossRefGoogle ScholarPubMed
Lader, M.Benzodiazepines revisited – will we ever learn?. Addiction 2011;106(12):2086–2109.CrossRefGoogle ScholarPubMed
Lader, M.Long-term anxiolytic therapy: the issue of drug withdrawal. J Clin Psychiatry 1987;48(Suppl.):12–16.Google ScholarPubMed
Lader, M.Use of benzodiazepines in the elderly population: do benefits outweigh risks?. Pandi-Perumal, S.R.Monti, J.M.Monjan, A.A.Principles and Practice of Geriatric Sleep medicine Cambridge: Cambridge Press; 2010.362–370.Google Scholar
Lader, M.Withdrawal reactions after stopping hypnotics in patients with insomnia. CNS Drugs 1998;10:425–440.CrossRefGoogle Scholar
Lader, M.H.Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?. Eur Neuropsychopharmacol 1999;9(Suppl. 6):399–405.CrossRefGoogle ScholarPubMed
Lader, M.Tylee, A.Donoghue, J.Withdrawing benzodiazepines in primary care. CNS Drugs 2009;23:19–34.CrossRefGoogle ScholarPubMed
Lagnaoui, R.Depont, F.Fourrier, A.Abouelfath, A.Begaud, B.Verdoux, H.Patterns and correlates of benzodiazepine use in the French general population. Eur J Clin Pharmacol 2004;60:523–529.CrossRefGoogle ScholarPubMed
Launchbury, A.P.Drake, J.Seager, H.Misuse of temazepam. BMJ 1992;305:252–253.CrossRefGoogle ScholarPubMed
Levine, D.A.“Pharming”: the abuse of prescription and over-the-counter drugs in teens. Curr Opin Pediatr 2007;19:270–274.CrossRefGoogle ScholarPubMed
Lima, A.R.Soares-Weiser, K.Bacaltchuk, J.Barnes, T.R.Benzodiazepines for neuroleptic-induced acute akathisia. Cochrane Database Syst Rev 2002;1:CD001950.Google Scholar
Linden, M.Bär, T.Helmchen, H.Prevalence and appropriateness of psychotropic drug use in old age; results from the Berlin Aging Study (BASE). Int Psychogeriatr 2004;16:461–480.CrossRefGoogle Scholar
Llorca, P.M.Spadone, C.Sol, O.Danniau, A.Bougerol, T.Corruble, E.Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study. J Clin Psychiatry 2002;63:1020–1027.CrossRefGoogle ScholarPubMed
Lonergan, E.Luxenberg, J.Areosa Sastre, A.Benzodiazepines for delirium. Cochrane Database Syst Rev 2009;4:CD006379.Google Scholar
Lucki, I.Rickels, K.Geller, A.M.Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology (Berl) 1986;88:426–433.CrossRefGoogle ScholarPubMed
Luijendijk, H.J.Tiermeier, H.Hofman, A.Heeringa, J.Stricker, B.H.Determinants of chronic benzodiazepine use in the elderly: a longitudinal study. Br J Clin Pharmacol 2007;65:593–599.CrossRefGoogle ScholarPubMed
Lydiard, R.B.Ballenger, J.C.Rickels, K.A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. J Clin Psychiatry 1997;58(Suppl. 11):11–18.Google ScholarPubMed
Martin, J.L.R.Sainz-Pardo, M.Furukawa, T.A.Martin-Sanchez, E.Seoane, T.Galan, C.Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J Psychopharmacol 2007;23:774–782.CrossRefGoogle Scholar
Martinez-Cano, H.Vela-Bueno, A.De Iceta, M.Pomalima, R.Martinez-Gras, I.Sobrino, M.P.Benzodiazepine types in high versus therapeutic dose dependence. Addiction 1996;91:1179–1186.CrossRefGoogle ScholarPubMed
Matar, M.A.Zohar, J.Kaplan, Z.Cohen, H.Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSD. Eur Neuropsychopharmacol 2009;19:283–295.CrossRefGoogle Scholar
McElhatton, P.R.The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 1994;8:461–475.CrossRefGoogle ScholarPubMed
Millar, H.L.Clunie, F.S.McGilchrist, M.M.McMahon, A.D.MacDonald, T.M.The impact of community benzodiazepine prescribing of hospitalization. J Psychosom Res 1997;42:61–69.CrossRefGoogle ScholarPubMed
Möller, H.J.Volz, H.P.Reimann, I.W.Stoll, K.D.Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group. J Clin Psychopharmacol 2001;21:59–65.CrossRefGoogle ScholarPubMed
Morishita, S.Clonazepam as a therapeutic adjunct to improve the management of depression: a brief review. Hum Psychopharmacol 2009;24:191–198.CrossRefGoogle ScholarPubMed
Munjack, D.J.Baltazar, P.L.Bohn, P.B.Cabe, D.D.Appleton, A.A.Clonazepam in the treatment of social phobia: a pilot study. J Clin Psychiatry 1990;51(Suppl.):35–40 [discussion 50–3].Google ScholarPubMed
Nakao, M.Takeuchi, T.Yano, E.Prescription of benzodiazepines and antidepressants to outpatients attending a Japanese university hospital. Int J Clin Pharmacol Ther 2007;45:30–35.CrossRefGoogle ScholarPubMed
Neutel, C.I.The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry 2005;17:189–197.CrossRefGoogle ScholarPubMed
Nolan, L.O’Malley, K.Patients, prescribing, and benzodiazepines. Eur J Clin Pharmacol 1988;35:225–229.CrossRefGoogle ScholarPubMed
O’Connor, K.Belanger, L.Marchand, A.Dupuis, G.Elie, R.Boyer, R.Psychological distress and adaptational problems associated with discontinuation of benzodiazepines. Addict Behav 1999;24:517–541.CrossRefGoogle ScholarPubMed
O’Connor, K.Marchand, A.Belanger, L.Mainguy, N.Landry, P.Savard, P.Turcotte, J.Psychological distress and adaptational problems associated with benzodiazepine withdrawal and outcome: a replication. Addict Behav 2004;29:583–593.CrossRefGoogle ScholarPubMed
Office of National Statistics. Psychiatric morbidity among adults living in private households, 2000. London: HMSO; 2006.Google Scholar
Ohayon, M.M.Caulet, M.Priest, R.G.Guilleminault, C.Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998;51:273–283.CrossRefGoogle ScholarPubMed
Oliver, PForrest, RKeen, J.Benzodiazepines and cocaine as risk factors in fatal opioid overdoses. National Treatment Agency for Substance Misuse April 2007 Research Briefing No. 31..Google Scholar
Orriols, L.Salmi, L.R.Philip, P.The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf 2009;18:647–658.CrossRefGoogle ScholarPubMed
Otto, M.W.Pollack, M.H.Gould, R.A.Worthington, J.J.McArdle, E.T.Rosenbaum, J.F.A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. J Anxiety Disord 2000;14:345–358.CrossRefGoogle ScholarPubMed
Parr, J.M.Kavanagh, D.J.Cahill, L.Mitchell, G.Young, R.M.Effectiveness of current treatment approaches for benzodiazepine discontinuation; a meta-analysis. Addiction 2008;104:13–24.CrossRefGoogle ScholarPubMed
Passarella, S.Duong, M.T.Diagnosis and treatment of insomnia. Am J Health Syst Pharm 2008;65:927–934.CrossRefGoogle ScholarPubMed
Paterniti, S.Dufouil, C.Alperovitch, A.Long-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging study. J Clin Psychopharmacol 2002;22:285–293.CrossRefGoogle ScholarPubMed
Paton, C.Benzodiazepines and disinhibition: a review. Psychiatr Bull. 2002;26:460–462.CrossRefGoogle Scholar
Peles, E.Schreiber, S.Adelson, M.Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT). Eur Neuropsychopharmacol 2007;18:188–193.CrossRefGoogle Scholar
Petursson, H.Lader, M.Dependence on tranquillizers. Maudsley Monograph No. 28. Oxford: Oxford University Press; 1984.Google Scholar
Pirnay, S.Borron, S.Giudicelli, C.Tourneau, J.Baud, F.Ricordel, I.A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction 2004;99:978–988.CrossRefGoogle ScholarPubMed
Prescription Services Division of the NHS Business Services Authority. http://www.nhsba.nhs.uk/PrescriptionServices.aspx. Accessed 30 October 2011.Google Scholar
Rapoport, M.J.Lanctôt, K.L.Streiner, D.L.Benzodiazepine use and driving: a meta-analysis. J Clin Psychiatry 2009;70:663–673.CrossRefGoogle ScholarPubMed
Reite, M.Treatment of Insomnia. Schatzberg, A.Nemeroff, C.B.Essentials of Clinical Psychopharmacology VA (USA): American Psychiatric Publishing; 2006.Google Scholar
Rickels, K.DeMartinis, N.Rynn, M.Mandos, L.Pharmacologic strategies for discontinuing benzodiazepine treatment. J Clin Psychopharmacol 1999;19:12–16.CrossRefGoogle ScholarPubMed
Rickels, K.Case, W.G.Downing, R.W.Winokur, A.Long-term diazepam therapy and clinical outcome. JAMA 1983;250:767–771.CrossRefGoogle ScholarPubMed
Rickels, K.DeMartinis, N.Aufdembrinke, B.A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder. J Clin Psychopharmacol 2000;20:12–18.CrossRefGoogle ScholarPubMed
Rickels, K.Downing, R.Schweizer, E.Hassman, H.Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry 1993;50:884–895.CrossRefGoogle ScholarPubMed
Rickels, K.Pollack, M.H.Feltner, D.E.Lydiard, R.B.Zimbroff, D.L.Bielski, R.J.Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry 2005;62:1022–1030.CrossRefGoogle ScholarPubMed
Rickels, K.Schweizer, E.DeMartinis, N.Mandos, L.Mercer, C.Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial. J Clin Psychopharmacol 1997;17:272–277.CrossRefGoogle ScholarPubMed
Ross, C.A.Matas, M.A clinical trial of buspirone and diazepam in the treatment of generalized anxiety disorder. Can J Psychiatry 1987;32:351–355.CrossRefGoogle ScholarPubMed
Royal College of Psychiatrists. Benzodiazepines: risks, benefits and dependence: a re-evaluation. Council Report 59:. http://www.rcpsych.ac.uk/ (London) 1997.Google Scholar
Russell, V.J.Lader, M.Guidelines for the prevention and treatment of benzodiazepine dependence. London; Mental Health Foundation; 1993.Google Scholar
Saïas, T.Gallarda, T.Paradoxical aggressive reactions to benzodiazepine use: a review. Encephale 2008;34:330–336.CrossRefGoogle ScholarPubMed
Salzman, C.Fisher, J.Nobel, K.Glassman, R.Wolfson, A.Kelley, M.Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Geriatr Psychiatry 1992;7:89–93.CrossRefGoogle Scholar
Salzman, C.Pharmacologic treatment of disturbed sleep in the elderly. Harv Rev Psychiatry 2008;16:271–278.CrossRefGoogle ScholarPubMed
Schweitzer, E.Rickels, K.Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand 1998;393:95–101.CrossRefGoogle Scholar
Seedat, S.Stein, M.B.Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder. J Clin Psychiatry 2004;65:244–248.Google ScholarPubMed
Seivewright, N.A.Dougal, W.Benzodiazepine misuse. Curr Opin Psychiatry 1992;5:408–411.CrossRefGoogle Scholar
Shader, R.I.Greenblatt, D.J.Benzodiazepine overuse-misuse. J Clin Psychopharmacol 1984;4:123–124.Google ScholarPubMed
Sheehan, M.F.Sheehan, D.V.Torres, A.Coppola, A.Francis, E.Snorting benzodiazepines. Am J Drug Alcohol Abuse 1991;17:457–468.CrossRefGoogle ScholarPubMed
Siriwardena, A.N.Qureshi, Z.Gibson, S.Collier, S.Latham, M.GPs’ attitudes to benzodiazepine and “Z-drug” prescribing: a barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract 2006;56:964–967.Google ScholarPubMed
Smith, A.J.Tett, S.E.Improving the use of benzodiazepines – is it possible? A non-systematic review of interventions tried in the last 20 years. BMC Health Serv Res 2010;10:321.CrossRefGoogle ScholarPubMed
Smith, W.T.Londborg, P.D.Glaudin, V.Painter, J.R.Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. Am J Psychiatry 1998;155:1339–1345.CrossRefGoogle ScholarPubMed
Soldatos, C.R.Dikeos, D.G.Whitehead, A.Tolerance and rebound insomnia with rapidly-eliminated hypnotics: a meta-analysis of sleep laboratory studies. Int Clin Psychopharmacol 1999;14:287–303.CrossRefGoogle ScholarPubMed
Spanemberg, L.Nogueira, E.L.Belem da Silva, C.T.Dargel, A.A.Menezes, F.S.Neto, A.C.High prevalence and prescription of benzodiazepines for elderly: data from psychiatric consultation to patients from an emergency room of a general hospital. Gen Hosp Psychiatry 2011;33:45–50.CrossRefGoogle ScholarPubMed
Spiegel, D.A.Psychological strategies for discontinuing benzodiazepine treatment. J Clin Psychopharmacol 1999;19(Suppl. 2):17–22.CrossRefGoogle ScholarPubMed
Stewart, S.A.The effects of benzodiazepines on cognition. J Clin Psychiatry 2005;66(Suppl. 2):9–13.Google ScholarPubMed
Stitzer, M.Griffiths, R.McLellan, A.Grabowski, J.Hawthorne, J.Diazepam use among methadone maintenance patients: patterns and dosages. Drug Alcohol Depend 1981;8:189–199.CrossRefGoogle ScholarPubMed
Stone, K.L.Ensrud, K.E.Ancoli-Israel, S.Sleep, insomnia and falls in elderly patients. Sleep Med 2008;9(Suppl. 1):18–22.CrossRefGoogle ScholarPubMed
Straand, J.Rokstad, K.General practitioners’ prescribing patterns of benzodiazepine hypnotics: Are elderly patients at particular risk for overprescribing? A report from the Møre & Romsdal Prescription Study. Scand J Prim Health Care 1997;15:16–21.CrossRefGoogle ScholarPubMed
Strang, J.Griffiths, P.Abbey, J.Gossop, M.Survey of use of injected benzodiazepines among drug users in Britain. BMJ 1994;308:1082.CrossRefGoogle ScholarPubMed
Tariq, S.H.Pulisetty, S.Pharmacotherapy for insomnia. Clin Geriatr Med 2008;24:93–105.CrossRefGoogle ScholarPubMed
Tata, P.R.Rollings, J.Collins, M.Lack of cognitive recovery following withdrawal from long-term benzodiazepine use. Psychol Med 1994;24:203–213.CrossRefGoogle ScholarPubMed
Taylor, S.McCracken, C.F.Wilson, K.C.Copeland, J.R.Extent and appropriateness of benzodiazepine use. Results from an elderly urban community. Br J Psychiatry 1998;173:433–438.CrossRefGoogle ScholarPubMed
Thase, M.E.Augmentation strategies for depression: history and concepts. CNS Spectr 2007;12(Suppl. 22):3–5.Google ScholarPubMed
Trevor, A.J.Way, L.W.Sedative-hypnotics. Basic and clinical pharmacology Mc Graw Hill Medical Publishing; Katzung editor; 1995.Google Scholar
Tu, K.Mamdani, M.M.Hux, J.E.Tu, J.B.Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada. J Am Geriatr Soc 2001;49:1341–1345.CrossRefGoogle ScholarPubMed
Department of Health U.K. the devolved administrations. Drug misuse and dependence: UK guidelines on clinical management. London; Department of Health; 2007.Google Scholar
van Laar, M.W.Volkerts, E.R.Driving and benzodiazepine use. Evidence that they do not mix. CNS Drugs 1998;10:383–396.CrossRefGoogle Scholar
Vasile, R.G.Bruce, S.E.Goisman, R.M.Pagano, M.Keller, M.B.Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in treatment of Generalized Anxiety Disorder and Social Phobia. Depress Anxiety 2005;22:59–67.CrossRefGoogle ScholarPubMed
Verdoux, H.Lagnaoui, R.Begaud, B.Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med 2005;35:307–315.CrossRefGoogle ScholarPubMed
Veronese, A.Garatti, M.Cipriani, A.Barbui, C.Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation. Eur J Clin Pharmacol 2007;63:867–873.CrossRefGoogle ScholarPubMed
Vikander, B.Koechling, U.M.Borg, S.Tönne, U.Hiltunen, A.J.Benzodiazepine tapering: a prospective study. Nord J Psychiatry 2010;64:273–282.CrossRefGoogle ScholarPubMed
Volz, A.Khorsand, V.Gillies, D.Leucht, S.Benzodiazepines for schizophrenia. Cochrane Database Syst Rev 2007;1:CD006391.Google Scholar
Voshaar, R.C.O.Couvee, J.E.Van Balkom, A.J.L.M.Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatry 2006;189:213–220.CrossRefGoogle ScholarPubMed
Windle, A.Elliot, E.Duszynski, K.Moore, V.Benzodiazepine prescribing in elderly Australian general practice patients. Aust N Z J Public Health 2007;31:379–381.CrossRefGoogle ScholarPubMed
Wolf, B.Grohmann, R.Biber, D.Brenner, P.M.Ruther, E.Benzodiazepine abuse and dependence in psychiatric inpatients. Pharmacopsychiatry 1989;22:54–60.CrossRefGoogle ScholarPubMed
Youssef, N.A.Rich, C.L.Does acute treatment with sedatives/hypnotics for anxiety in depressed patients affect suicide risk? A literature review. Ann Clin Psychiatry 2008;20:157–169.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.